Panic attacks, frequently characterized by sudden, intense episodes of fear accompanied by physiological symptoms such as tachycardia, dizziness, and hyperventilation, remain a debilitating facet of panic disorder. The pathophysiology underlying these attacks, particularly those triggered by hypercapnia (elevated CO₂ levels), involves intricate neurobiological mechanisms including neuroinflammation and dysregulation within brain circuits governing fear and anxiety. The novelty of the research lies in targeting these biological underpinnings through repurposing minocycline, traditionally known for its antimicrobial and anti-inflammatory properties, suggesting a dual role far beyond infection control.

The experimental design adopted by de Oliveira and colleagues employed a well-validated CO₂ challenge model, which reliably evokes panicogenic responses mirroring human panic attacks. In this paradigm, rodents are exposed to increased CO₂ concentrations, invoking neurobehavioral changes that serve as a proxy for panic symptoms. By applying minocycline in this setting, the researchers scrutinized its efficacy in attenuating these panic-like behaviors, thus providing mechanistic insight into the drug’s potential neuroprotective and anxiolytic effects.

Central to the study’s findings is the observed modulation of neuroinflammatory markers following minocycline administration. Hypercapnia is known to activate microglial cells—the brain’s resident immune population—culminating in the release of pro-inflammatory cytokines that exacerbate neuronal excitability and panic symptoms. Minocycline’s capacity to inhibit microglial activation disrupts this deleterious cascade, leading to measurable reductions in panic-like behaviors. This phenomenon underscores the critical role of neuroimmune interactions in panic pathophysiology and positions anti-inflammatory approaches as viable therapeutic targets.

Moreover, the study delved into neurotransmitter systems implicated in panic responses, notably the balance between gamma-aminobutyric acid (GABA) and glutamate neurotransmission. Elevated CO₂ typically disrupts this equilibrium, enhancing excitatory glutamatergic signaling while impairing inhibitory GABAergic tone, thereby precipitating panic attacks. Minocycline’s influence appears to restore this neurotransmitter homeostasis, potentially through indirect modulation of synaptic plasticity mechanisms and neuroinflammation-related pathways, offering a multifaceted mechanism of action.

Translational relevance was reinforced through comprehensive behavioral assessments including elevated plus maze and open field tests, where minocycline-treated subjects displayed significantly reduced anxiety and panic-like indicators compared to controls. Such behavioral amelioration suggests that minocycline’s benefits transcend molecular changes, manifesting in observable functional recovery. Importantly, the dosing regimens used align with clinically acceptable levels, strengthening the foundation for future human trials.

Beyond individual symptom management, this research carries profound implications for understanding panic disorder at the system level. It advocates a paradigm shift from purely neurochemical interventions towards integrated neuroimmune and neuroinflammatory frameworks. Considering that current panic disorder treatments, such as selective serotonin reuptake inhibitors and benzodiazepines, often present limitations including delayed onset and adverse effects, minocycline or similar agents could augment or potentially replace conventional therapies with enhanced safety profiles.

The novelty and depth of this study also underscore the broader concept of drug repurposing in psychiatry. Minocycline’s established pharmacokinetics and safety record expedite the translational pipeline, reducing the barriers traditionally associated with new drug development. This accelerates the prospect of timely clinical application, fulfilling a critical unmet need for more effective panic disorder interventions.

Additionally, the neuroprotective properties of minocycline invite exploration into comorbid conditions frequently accompanying panic disorder, such as depression and post-traumatic stress disorder, both involving neuroinflammatory processes. This multifaceted potential amplifies the significance of the findings, positioning minocycline as a promising candidate for broader psychiatric use.

Future research avenues highlighted by de Oliveira et al. include delineating the precise molecular targets of minocycline within the panic circuitry, longitudinal studies to assess sustained treatment effects, and clinical trials to validate efficacy and tolerability in human populations. These steps are crucial for confirming translatability and establishing clinical guidelines.

In conclusion, the innovative approach adopted by this study not only expands the understanding of panic disorder biology but also carves a path for innovative, inflammation-targeted therapeutics. By attenuating CO₂-induced panicogenic responses with minocycline, the research champions a new frontier that interlaces immunology, neuropharmacology, and psychiatry, potentially transforming treatment landscapes for millions afflicted by panic attacks worldwide.

As the mental health field grapples with the complexity of anxiety disorders, breakthroughs such as this invigorate hope, shining a light on novel mechanisms and safe, effective treatments capable of alleviating the profound impact of panic disorder on individuals’ lives.

Subject of Research:
The research focuses on the therapeutic effects of minocycline on panicogenic responses induced by elevated CO₂ levels, investigating neurobiological mechanisms underlying panic attacks in a translational model.

Article Title:
Minocycline attenuates panicogenic responses in a CO₂-induced panic attack model: a translational approach.

Article References:
de Oliveira, B.F.G., Quagliato, L.A., Frias, A.T. et al. Minocycline attenuates panicogenic responses in a CO₂-induced panic attack model: a translational approach. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-03836-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-03836-7

At the helm of the BRIGHT Center is Dr. Carla Kmett Danielson, a clinical psychologist and an esteemed faculty member of MUSC’s Department of Psychiatry and Behavioral Sciences. Dr. Danielson’s appointment as the center’s director reflects a historic milestone, marking the first time a woman leads a COBRE at MUSC and the inaugural leadership of this center within the Department of Psychiatry. She is joined by Dr. Kenneth Ruggiero, a distinguished researcher from the College of Nursing, who will co-direct the center. Collectively, their leadership promises a multidisciplinary approach that integrates psychology, nursing, and public health to address the multifaceted challenges of trauma.

The urgency behind the BRIGHT Center’s formation is underscored by epidemiological evidence demonstrating that approximately 75% of Americans endure a potentially traumatic event during childhood or adolescence. These experiences contribute substantially to a spectrum of mental and physical health disorders, imposing an estimated economic burden exceeding $300 billion annually on the U.S. healthcare system. Despite many individuals demonstrating natural resilience, the long-term sequelae of trauma for millions manifest as chronic psychiatric conditions, substance misuse, and psychosomatic illnesses, highlighting a critical need for scalable, evidence-based therapeutic interventions.

Access to mental health care remains a persistent barrier. Data from the National Alliance on Mental Illness reveal that while one in five Americans experiences a mental health disorder yearly, more than half do not receive appropriate treatment due to cost constraints and a scarcity of mental health professionals, particularly in underserved regions. In South Carolina specifically, over 700,000 adults have been diagnosed with mental health conditions with millions living in areas with insufficient access to mental health services. The BRIGHT Center intends to bridge this divide by developing and disseminating innovative interventions tailored to reach the populations most in need.

The core philosophy of the BRIGHT Center emphasizes empowerment and capacity-building among early-career trauma researchers. By offering mentoring, state-of-the-art resources, and cross-disciplinary collaboration, the center aspires to cultivate a cadre of scientists who will drive the field forward through rigorous research and innovative treatment development. This approach ensures sustainability by enabling emerging investigators to secure independent funding and establish laboratories dedicated to trauma recovery science, thus reinforcing MUSC’s leadership in this critical domain.

Central to the BRIGHT Center’s infrastructure are three specialized research cores designed to synergistically advance trauma research and treatment innovation. The Digital Health Core leverages cutting-edge technology, including mobile health applications and artificial intelligence, to create interventions that are not only efficacious but also scalable and accessible. Under Dr. Ruggiero’s guidance, this core collaborates with experts such as Dr. Jihad Obeid and Dr. Leigh Ridings to harness technological tools that enhance patient engagement and personalize care delivery in real time.

Parallel to technological innovation, the Community Engagement Core focuses on culturally sensitive research practices that actively involve community stakeholders. Led by Drs. Marvella Ford, Cristina Lopez, and Colleen Halliday, this core fosters participatory research methodologies, ensuring that trauma interventions resonate with diverse populations and address specific community needs. By integrating feedback from survivors, providers, and public health entities, this core enhances the relevance, acceptability, and impact of trauma interventions.

The Dissemination and Implementation Science Core completes the trifecta by addressing a critical translational challenge: ensuring that effective interventions are adopted widely and delivered with fidelity in real-world settings. This core, directed by Drs. Rochelle Hanson, Dee Ford, and Emily Johnson, employs rigorous methodologies to optimize intervention uptake among providers and communities, thus mitigating the well-documented “implementation gap” that often thwarts the transition from research to practice. This focus ensures that innovations developed within the BRIGHT Center translate into tangible improvements in public health outcomes.

Among the first cohort of researchers supported by the center are Dr. Christine Hahn, Dr. Hannah Espeleta, and Dr. Guillermo Wippold, whose pioneering projects exemplify the center’s integrated approach. Dr. Hahn is developing the first smartphone application designed to augment treatment for traumatic stress and substance misuse in sexual assault centers. This digital tool leverages real-time support mechanisms to increase access to timely, evidence-based care for survivors, demonstrating the potential of mHealth technologies to revolutionize trauma intervention paradigms.

Dr. Espeleta’s research addresses the critical shortage of accessible evidence-based home visiting programs aimed at preventing child maltreatment. By investigating a novel hybrid model that combines in-person and virtual visits, her pilot clinical trial explores strategies to expand reach, particularly to high-risk populations in rural communities. This work is poised to inform scalable, adaptable approaches that can ameliorate early-life adversities integral to lifelong health trajectories.

Dr. Wippold’s project digitizes a comprehensive program targeting health-related quality of life enhancements—integrating nutritional guidance, physical activity promotion, and trauma mitigation strategies tailored for men. The development of a digital platform enhances user engagement and scalability, reflecting the center’s commitment to leveraging technology for broad public health impact. Together, these projects encapsulate the BRIGHT Center’s commitment to harmonizing digital innovation, community engagement, and implementation science to address trauma’s complex consequences.

The BRIGHT Center’s strategic investments in early-career investigators promise to foster a new generation of trauma researchers adept at utilizing interdisciplinary tools and methodologies. The emphasis on “process over content” in clinical psychology, championed by Dr. Danielson, underscores the importance of mastering the delivery mechanisms of interventions alongside their content, ensuring versatility and adaptability across diverse clinical and community settings. This philosophy reflects a sophisticated understanding that scalable impact in trauma care requires attention to both the “how” and the “what” of treatment.

Looking forward, Dr. Danielson envisions the BRIGHT Center as a transformative catalyst that not only pioneers innovative trauma interventions but also redefines their implementation and communication. By bridging treatment gaps through a combination of scientific rigor and community responsiveness, the center aspires to engender systemic change in trauma care delivery, thereby improving outcomes for countless individuals across South Carolina and beyond. This vision aligns with a broader public health imperative to move from reactive treatment models to proactive, resilience-building approaches that can mitigate the long-term burden of trauma on society.

As the BRIGHT Center commences its pioneering work, it invites collaboration and engagement from researchers, clinicians, and community partners alike. Through this integrated framework, MUSC solidifies its position at the forefront of trauma research and intervention sciences, promising a future where trauma survivors are supported not merely to survive but to thrive. For those seeking further information or partnership opportunities, the center’s research program coordinator, Charli Kirby, stands ready to facilitate connections and expand the center’s reach.

Medical University of South Carolina continues to uphold its century-and-a-half legacy of excellence in education, research, and patient care. As the state’s premier academic health system, with a robust enterprise budget and a cadre of world-class faculty and scientists, MUSC’s establishment of the BRIGHT Center exemplifies its commitment to addressing pressing public health challenges through innovative biomedical research. The center’s integration of technology, community engagement, and implementation science embodies the future of trauma care—a future defined by resilience, hope, and transformative impact.

Subject of Research: Trauma recovery, resilience building, and innovative intervention development following traumatic stress.

Article Title: Medical University of South Carolina Launches BRIGHT Center to Transform Trauma Recovery through Innovative Interventions and Technological Integration

News Publication Date: Not provided in source content

Web References:
– https://education.musc.edu/muscapps/facultydirectory/Danielson-Carla
– https://medicine.musc.edu/departments/psychiatry
– https://education.musc.edu/muscapps/facultydirectory/Ruggiero-Kenneth
– https://nursing.musc.edu/
– https://nursing.musc.edu/research/centers/tachl
– https://education.musc.edu/MUSCApps/facultydirectory/Obeid-Jihad
– https://medicine.musc.edu/departments/phs
– https://education.musc.edu/muscapps/facultydirectory/Ridings-Leigh
– https://education.musc.edu/muscapps/facultydirectory/ford-marvella
– https://education.musc.edu/muscapps/facultydirectory/Lopez-Cristina
– https://education.musc.edu/MUSCApps/FacultyDirectory/Halliday-Colleen
– https://education.musc.edu/muscapps/facultydirectory/Hanson-Rochelle
– https://education.musc.edu/muscapps/facultydirectory/Ford-Dee
– https://education.musc.edu/MUSCApps/facultydirectory/Johnson-Emily
– https://education.musc.edu/muscapps/facultydirectory/Hahn-Christine
– https://education.musc.edu/MUSCApps/facultydirectory/Espeleta-Hannah

References: Not explicitly provided in source content.

Image Credits: Medical University of South Carolina. Photo by Julie Taylor.

Keywords: Trauma Recovery, Resilience Building, Digital Health Intervention, Community Engagement, Implementation Science, Mental Health Access, Mobile Health, Trauma Research, Clinical Psychology, Biomedical Research, Health Disparities, Early-Career Investigator Training